Literature DB >> 26687188

Evidence for Mitochondrial UPR Gene Activation in Familial and Sporadic Alzheimer's Disease.

John S Beck, Elliott J Mufson, Scott E Counts1.   

Abstract

Mitochondrial perturbations such as oxidative stress, increased fission/fusion dysfunction, and mitophagy are consistent features of Alzheimer's disease (AD), yet the mechanisms that initiate these perturbations are unclear. One potential source for mitochondrial defects could be an imbalance in mitochondrial proteostasis. In this regard, studies indicate that a specialized mitochondrial unfolded protein response (mtUPR) is activated upon the aberrant accumulation of damaged or unfolded proteins in the mitochondrial matrix, resulting in the up-regulation of key genes involved in mitochondrial stabilization. To test whether mtUPR activation occurs in AD, we performed real-time quantitative PCR on postmortem frontal cortex samples from subjects classified as sporadic AD, familial AD linked to presenilin-1 mutations, or cognitively intact controls. Compared to controls, sporadic AD subjects exhibited a significant ~40-60% increase in expression levels of select genes activated by the mtUPR, including mitochondrial chaperones dnaja3, hspd1, and hspe1, mitochondrial proteases clpp and yme1l1, and txn2, a mitochondrial-specific oxidoreductase. Furthermore, levels of all six mtUPR genes were significantly up-regulated by ~70-90% in familial AD compared to controls, and these expression levels were significantly higher compared to sporadic AD. The increase in hspd1 (Hsp60) was validated by western blotting. These data support the concept that both sporadic and familial AD are characterized by mtUPR gene activation. Understanding the physiological consequences of this response may provide subcellular mechanistic clues to selective neuronal vulnerability or endogenous compensatory mechanisms during the progression of AD.

Entities:  

Mesh:

Year:  2016        PMID: 26687188      PMCID: PMC5977398          DOI: 10.2174/1567205013666151221145445

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  30 in total

Review 1.  Is Alzheimer's disease a disorder of mitochondria-associated membranes?

Authors:  Eric A Schon; Estela Area-Gomez
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 2.  Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease.

Authors:  Xiongwei Zhu; George Perry; Paula I Moreira; Gjumrakch Aliev; Adam D Cash; Keisuke Hirai; Mark A Smith
Journal:  J Alzheimers Dis       Date:  2006-07       Impact factor: 4.472

3.  Transcriptional profiling of small samples in the central nervous system.

Authors:  Stephen D Ginsberg
Journal:  Methods Mol Biol       Date:  2008

4.  Mortalin is regulated by APOE in hippocampus of AD patients and by human APOE in TR mice.

Authors:  Cristina Osorio; Patrick M Sullivan; Dong Ning He; Brian E Mace; John F Ervin; Warren J Strittmatter; Oscar Alzate
Journal:  Neurobiol Aging       Date:  2006-10-16       Impact factor: 4.673

5.  Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment.

Authors:  Scott E Counts; Muhammad Nadeem; Shivanand P Lad; Joanne Wuu; Elliott J Mufson
Journal:  J Neuropathol Exp Neurol       Date:  2006-06       Impact factor: 3.685

Review 6.  A synergistic dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer's disease.

Authors:  Renato X Santos; Sónia C Correia; Xinglong Wang; George Perry; Mark A Smith; Paula I Moreira; Xiongwei Zhu
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 7.  Evaluating and responding to mitochondrial dysfunction: the mitochondrial unfolded-protein response and beyond.

Authors:  Cole M Haynes; Christopher J Fiorese; Yi-Fan Lin
Journal:  Trends Cell Biol       Date:  2013-03-13       Impact factor: 20.808

8.  Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system.

Authors:  A M Cataldo; J L Barnett; S A Berman; J Li; S Quarless; S Bursztajn; C Lippa; R A Nixon
Journal:  Neuron       Date:  1995-03       Impact factor: 17.173

Review 9.  Mitochondrial control of autophagic lysosomal pathway in Alzheimer's disease.

Authors:  S M Cardoso; C F Pereira; P I Moreira; D M Arduino; A R Esteves; C R Oliveira
Journal:  Exp Neurol       Date:  2009-06-25       Impact factor: 5.330

10.  Mitonuclear protein imbalance as a conserved longevity mechanism.

Authors:  Riekelt H Houtkooper; Laurent Mouchiroud; Dongryeol Ryu; Norman Moullan; Elena Katsyuba; Graham Knott; Robert W Williams; Johan Auwerx
Journal:  Nature       Date:  2013-05-23       Impact factor: 49.962

View more
  36 in total

1.  Mutant huntingtin inhibits the mitochondrial unfolded protein response by impairing ABCB10 mRNA stability.

Authors:  Zixing Fu; Fang Liu; Chunyue Liu; Beifang Jin; Yueqing Jiang; Mingliang Tang; Xin Qi; Xing Guo
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-02-23       Impact factor: 5.187

2.  Mitochondrial retrograde signalling in neurological disease.

Authors:  Lucy Granat; Rachel J Hunt; Joseph M Bateman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2020-05-04       Impact factor: 6.237

Review 3.  The mitochondrial UPR: mechanisms, physiological functions and implications in ageing.

Authors:  Tomer Shpilka; Cole M Haynes
Journal:  Nat Rev Mol Cell Biol       Date:  2017-11-22       Impact factor: 94.444

Review 4.  Mitochondrial cross-compartmental signalling to maintain proteostasis and longevity.

Authors:  Marte Molenaars; Eileen G Daniels; Amber Meurs; Georges E Janssens; Riekelt H Houtkooper
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2020-05-04       Impact factor: 6.237

5.  Regulator of Cell Cycle (RGCC) Expression During the Progression of Alzheimer's Disease.

Authors:  Scott E Counts; Elliott J Mufson
Journal:  Cell Transplant       Date:  2016-11-30       Impact factor: 4.064

Review 6.  Mitochondria-Targeted Therapeutics for Alzheimer's Disease: The Good, the Bad, the Potential.

Authors:  Yashi Mi; Guoyuan Qi; Roberta Diaz Brinton; Fei Yin
Journal:  Antioxid Redox Signal       Date:  2020-04-21       Impact factor: 8.401

Review 7.  Mitochondrial function in development and disease.

Authors:  Marlies P Rossmann; Sonia M Dubois; Suneet Agarwal; Leonard I Zon
Journal:  Dis Model Mech       Date:  2021-06-11       Impact factor: 5.758

Review 8.  Mitochondrial Dysfunction and Mitophagy Closely Cooperate in Neurological Deficits Associated with Alzheimer's Disease and Type 2 Diabetes.

Authors:  Sangita Paul; Debarpita Saha; Binukumar Bk
Journal:  Mol Neurobiol       Date:  2021-04-01       Impact factor: 5.590

Review 9.  Mitochondrial Dysfunction as a Driver of Cognitive Impairment in Alzheimer's Disease.

Authors:  Chanchal Sharma; Sehwan Kim; Youngpyo Nam; Un Ju Jung; Sang Ryong Kim
Journal:  Int J Mol Sci       Date:  2021-05-03       Impact factor: 5.923

Review 10.  Interplay between Mitochondrial Protein Import and Respiratory Complexes Assembly in Neuronal Health and Degeneration.

Authors:  Hope I Needs; Margherita Protasoni; Jeremy M Henley; Julien Prudent; Ian Collinson; Gonçalo C Pereira
Journal:  Life (Basel)       Date:  2021-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.